PERSONALIZED RX

Personalized Rx is designed to provide physicians and other health-care and research professionals with accurate prognostication, and to highlight the benefits of potential courses of treatment of non-small cell lung cancer (NSCLC). Currently, the model utilizes information about an individual patient to provide an estimate of disease-specific survival. Multiple factors are combined to give an integrated risk-assessment based on the clinical data of thousands of patients diagnosed with lung adenocarcinoma and squamous cell lung cancer. For each patient, estimates on overall survival, treatment-specific survival, and an estimation of risk relative to other patients are provided in graphical and text format.